modified recombinant fish parvalbumin

Recombinant proteinexperimental

Clinical trial activity

2 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Aug 1, 2013 (NCT02017626)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • modified recombinant fish parvalbumin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02382718Phase 2Oct 1, 2015FAST Consortium under EU 7th FP, Medical University of Lodz, Universidad Complutense de Madrid, Universidad de Cordoba, University of Athens, University of Copenhagen, University of Iceland, University of Malaga, University of Southern Denmark, Utrecht University
NCT02017626Phase 1/Phase 2 (Phase 2)Aug 1, 2013University of Copenhagen, University of Southern Denmark
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of CopenhagenAcademic/Hospital2112013
University of Southern DenmarkAcademic/Hospital2012013
FAST Consortium under EU 7th FPAcademic/Hospital1012015
Medical University of LodzAcademic/Hospital1012015
Universidad Complutense de MadridAcademic/Hospital1012015
Universidad de CordobaAcademic/Hospital1012015
University of AthensAcademic/Hospital1112015
University of IcelandAcademic/Hospital1012015
University of MalagaAcademic/Hospital1012015
Utrecht UniversityAcademic/Hospital1012015
10 organizations
Page 1 / 1